Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,548 results for ""ANTIVIRAL agents""

Your Filters

Publisher : springer
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population.

  • Authors : Itani MI; Department of Internal Medicine, Division of Gastroenterology & Hepatology, Wayne State University School of Medicine, Detroit, MI, 48201, USA.; Farah B

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/epidemiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/virology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Sep; Vol. 55 (3), pp. 1324-1332. Date of Electronic Publication: 2024 Jul 08.Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Anti-coronavirus and anti-pulmonary inflammation effects of iridoids, the common component from Chinese herbal medicines for the treatment of COVID-19.

  • Authors : Huang DY; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, 260 Baichuan St, Hangzhou, 311402, People's Republic of China.; School of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, 99 Yingbin Ave, 529020, Jiangmen, People's Republic of China.

Subjects: Iridoids*/Iridoids*/Iridoids*/pharmacology ; Iridoids*/Iridoids*/Iridoids*/chemistry ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology

  • Source: Journal of natural medicines [J Nat Med] 2024 Sep; Vol. 78 (4), pp. 1003-1012. Date of Electronic Publication: 2024 May 22.Publisher: Springer Country of Publication: Japan NLM ID: 101518405 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients.

  • Authors : Platzer M; 4. Med. Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Wiener Gesundheitsverbund, Vienna, Austria.; Totschnig D

Subjects: Alanine*/Alanine*/Alanine*/analogs & derivatives ; Alanine*/Alanine*/Alanine*/therapeutic use ; Alanine*/Alanine*/Alanine*/administration & dosage

  • Source: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2024 Aug; Vol. 136 (15-16), pp. 458-464. Date of Electronic Publication: 2024 Jun 17.Publisher: Springer Country of Publication: Austria NLM ID: 21620870R Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[HIV and hepatitis B and hepatitis C coinfection: Treatment and practical experiences].

  • Authors : Breitschwerdt S; nfektionsambulanz/HIV, Medizinische Klinik I, Universitätsklinikum Bonn, Bonn, Deutschland.; Boesecke C

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Coinfection*/Coinfection*/Coinfection*/drug therapy

  • Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2024 Jul; Vol. 166 (Suppl 2), pp. 38-43.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4.

  • Authors : He T; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, 200040, China.; Chen B

Subjects: Telbivudine*/Telbivudine*/Telbivudine*/therapeutic use ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/blood

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Jul; Vol. 80 (7), pp. 1029-1038. Date of Electronic Publication: 2024 Mar 19.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Flow analysis-solid phase extraction system and UHPLC-MS/MS analytical methodology for the determination of antiviral drugs in surface water.

  • Authors : Mermer K; Doctoral School of Exact and Natural Sciences, Jagiellonian University, Łojasiewicza 11, 30-348, Kraków, Poland. .; Department of Analytical Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387, Kraków, Poland. .

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/analysis ; Solid Phase Extraction* ; Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods

  • Source: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2024 Aug; Vol. 31 (37), pp. 49546-49559. Date of Electronic Publication: 2024 Jul 30.Publisher: Springer Country of Publication: Germany NLM ID: 9441769 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study.

  • Authors : Ishida H; Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan.; Goto N

Subjects: Acetates*/Acetates*/Acetates*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Cytomegalovirus Infections*/Cytomegalovirus Infections*/Cytomegalovirus Infections*/prevention & control

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Aug; Vol. 28 (8), pp. 822-831. Date of Electronic Publication: 2024 Apr 13.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis.

  • Authors : Zhang PX; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, 230601, China.; Tang QQ

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/blood ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use

  • Source: Hepatology international [Hepatol Int] 2024 Aug; Vol. 18 (4), pp. 1110-1121. Date of Electronic Publication: 2024 Jun 24.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The Inhibitory Effect of Resveratrol from Reynoutria japonica on MNV-1, a Human Norovirus Surrogate.

  • Authors : Lu F; School of Life Sciences, China Jiliang University, Hangzhou, 310018, China.; Wang J

Subjects: Resveratrol*/Resveratrol*/Resveratrol*/pharmacology ; Resveratrol*/Resveratrol*/Resveratrol*/chemistry ; Norovirus*/Norovirus*/Norovirus*/drug effects

  • Source: Food and environmental virology [Food Environ Virol] 2024 Jun; Vol. 16 (2), pp. 241-252. Date of Electronic Publication: 2024 Apr 03.Publisher: Springer Country of Publication: United States NLM ID: 101483831 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2.

  • Authors : Otazu K; Laboratório de Modelagem Computacional - LaModel, Instituto de Ciências Exatas - ICEx, Universidade Federal de Alfenas-UNIFAL-MG, Alfenas, Minas Gerais, Brazil.; Olivos-Ramirez GE

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/chemistry ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/metabolism ; Molecular Docking Simulation*

  • Source: Journal of molecular modeling [J Mol Model] 2024 Jun 18; Vol. 30 (7), pp. 217. Date of Electronic Publication: 2024 Jun 18.Publisher: Springer Country of Publication: Germany NLM ID: 9806569 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  4,548 results for ""ANTIVIRAL agents""